Navigation Links
Molecular miners find pain relief drugs from the sea

Melbourne based company Metabolic Pharmaceuticals Limited recently announced successful results in preclinical trials of the toxin. The company will begin clinical trials in humans this month to firstly test the safety of the toxin in normal males, and later its effectiveness in treating the neuropathic pain associated with diabetes.

From the University of Melbourne's Department of Biochemistry and Molecular Biology and the recently launched Bio21 Institute, Associate Professor Bruce Livett says the toxin ?called ACV1 ?also has potential for treating a range of other painful conditions, such as multiple sclerosis, shingles and sciatica.

"ACV1 has been shown to be effective in treating pain in several experimental animal models of human pain syndromes, including post-surgical and neuropathic pain," Associate Professor Livett says.

"In addition, it has the unique property that it appears to accelerate the rate of recovery from a nerve injury."

"We are very excited that clinical trials to test the effectiveness of ACV1 in humans with diabetic neuropathies will soon be underway and we expect that the potential of ACV1 in treating a range of other painful conditions will also be realised in time."

ACV1 has shown potential for treating neuropathic pain, that is, pain generated inside the body (arising in the nervous system) as opposed to the other type of pain ?nociceptive pain ?which comes from the outside in, for example, a burn.

Associate Professor Livett says neuropathic pain is the most difficult form to treat and typically responds poorly to conventional painkillers such as morphine or aspirin. Other treatments have also been found to be largely ineffective.

The great potential of ACV1 is that eliminating neuropathic pain is where it works best.

BACKGROUND

Associate Professor Livett and his colleagues first discovered ACV1 in 2003 while studying the toxins produced in the venom of Conus victoriae
'"/>

Source:University of Melbourne


Page: 1 2 3

Related biology news :

1. Molecular biology fills gaps in knowledge of bat evolution
2. Molecular machine may lead to new drugs to combat human diseases
3. Molecular Motors Cooperate In Moving Cellular Cargo, Study Shows
4. Molecular models advance the fight against malaria
5. Molecular fossils uncover link between viruses and the immune system
6. Molecular thermometers on skin cells detect heat and camphor
7. Molecular messengers perform a crucial role in the ability of injured nerve cells to heal themselves
8. Molecular steps involved in the creation of gene-silencing microRNAs identified
9. Molecular mechanism of feather formation found
10. Molecular trigger for Huntingtons disease found
11. Molecular Partners Required For Appropriate Neuronal Gene Repression

Post Your Comments:
(Date:11/23/2009)...rovides "incontrovertible evidence" that the volca...a about 73,000 years ago deforested much of centra...archers report. , The volcano ejected an estimat..., leaving a crater (now the world,s largest volcan...ters wide. Ash from the event has been found in In...
(Date:11/23/2009)...y by University of Alabama at Birmingham (UAB) res...xisting medical conditions (co-morbidity) do not e...an-Americans compared to Caucasians who also have ...3 in Cancer , a journal of the American Cancer So... and co-morbidity are independent predictors of po...
(Date:11/23/2009)...ent discoveries about the multiple health benefits...urpose nutrient, increased awareness of the huge n...research and even led to an appreciation of it as ...the health of your immune system to prevention of ... vitamin D is now seen as one of the most critical...
Breaking Biology News(10 mins):Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Reportable Food Registry Draft Guidance Published for Comment by FDA 49058 1Reportable Food Registry Draft Guidance Published for Comment by FDA 49058 2Gaiam and Discovery Communications Announce Exclusive Licensing Deal 49055 1Gaiam and Discovery Communications Announce Exclusive Licensing Deal 49055 2Gaiam and Discovery Communications Announce Exclusive Licensing Deal 49055 3Steelcase Inc Receives Five Best of NeoCon Awards and Best Overall Showroom for Nurture at NeoCon 2009 49052 1Steelcase Inc Receives Five Best of NeoCon Awards and Best Overall Showroom for Nurture at NeoCon 2009 49052 2Steelcase Inc Receives Five Best of NeoCon Awards and Best Overall Showroom for Nurture at NeoCon 2009 49052 3
... CLEVELAND The National Science Foundation (NSF)...University to prepare 24 high-achieving science an...e newly funded Robert Noyce Teacher Scholarship Pr...ase Western Reserve will seek to encourage science... and science teachers. The nearly $750,000 grant w...
... , For the first time, scientists have decoded the...isease - acute myelogenous leukemia - to its genet...encing Center and the Siteman Cancer Center at Was... sequenced the genome of the patient - a woman in ...he genome of her leukemia cells, to identify genet...
... In the study, the scientists screened known drug...e conventional reprogramming genes, which can have... new way to generate stem cells from fibroblasts, ...cessible from various tissues, including skin. , ...ition (Volume 3, Issue 5) of the journal Cell Ste...
Other Biology News:NSF grant to launch undergrads from Case Western Reserve into math and science teaching 2NSF grant to launch undergrads from Case Western Reserve into math and science teaching 3Washington University scientists first to sequence genome of cancer patient 2Washington University scientists first to sequence genome of cancer patient 3Washington University scientists first to sequence genome of cancer patient 4Washington University scientists first to sequence genome of cancer patient 5Scripps research scientists identify compounds for stem-cell production from adult cells 2Scripps research scientists identify compounds for stem-cell production from adult cells 3
(Date:11/24/2009)...yendpointhasbeenmetforpatientswithadvanced-stage,o....24/PRNewswire-FirstCall/-AEternaZentarisInc.(NASD...euticalcompanyfocusedonendocrinetherapyandoncology...ywithitstargetedcytotoxicpeptideconjugate,AEZS-108...endometrialcancer.Inapersonalizedhealthcareapproac...
(Date:11/24/2009)...r24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASDA...any,today,announcedthatithassubmittedaMAAtotheEuro...y,senzymereplacementtherapyindevelopment,forthetre...g,applicationforvelaglucerasealfathathasbeensubmit...nada. , Basedonaglobalsupplyshortageofthecurr...
(Date:11/24/2009)...lif.,Nov.24/PRNewswire-FirstCall/--GenomicHealth,I...omicHealth,sExecutiveChairman,willpresentatthe21st...yonTuesday,December1,2009at10:00a.m.ET. ,, Toac...entation,visittheInvestorRelationssectionofGenomic...m .Pleaseconnecttothewebsiteatleast15minutespriort...
(Date:11/24/2009)... Program Connects Customers with Partners Valid... DNA Genotek Products , O...k , a leading provider of products for biological ...today announced its new global partner program. Th...Genotek,s partner community and is designed to hel...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...quivalent to Humulin(R) R (recombinant human, i...all/ - SemBioSys Genetics Inc. (TSX:SBS), speciali... oils in plant seeds, today announced preliminary ...S-1000, a recombinant human insulin manufactured u...ted that SBS-1000 was bioequivalent to a recombina...
...9 Based on its recent analysis of the device biol...ech with the 2009 North American Frost & Sulli...s market is one of the most lucrative in the medic...ld has already experienced periods of breakthrough... , (Logo: http://www.newscom.com/cgi-bin/prnh/20...
...nomic, Inc. (OTC Bulletin Board: TBIO) today annou...year ended December 31, 2008. The Company,s financ...w. , , Fourth Quarter 2008 , The Company report...he fourth quarter of 2008 as compared to a net inc...quarter of 2007. , , Net sales from continuing op...
Other Biology Technology:SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin 2SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin 3SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin 4Frost & Sullivan Recognizes ApaTech's Leadership in Orthopedic Biologics 2Frost & Sullivan Recognizes ApaTech's Leadership in Orthopedic Biologics 3Frost & Sullivan Recognizes ApaTech's Leadership in Orthopedic Biologics 4Frost & Sullivan Recognizes ApaTech's Leadership in Orthopedic Biologics 5Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results 2Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results 3Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results 4Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results 5Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results 6Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results 7Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results 8
pBICEP-CMV-3 Expression Vector from Sigma-Aldrich
... direct antibiotic-based selection system for reco...nds solely on colony survival, eliminating the nee...ensive process provides close to 100% accuracy in ...l platform for robot colony picking. This cloning ...
Eppendorf Thermomixer from Eppendorf North America
Mouse Anti-Human KCTD13 Polyclonal Antibody, Unconjugated from Abnova Corporation
Biology Products: